SYNTHESIS NON LIVING COMPOUNDS THAT

Brand	Owner	Address	Description
CTI	CELL THERAPEUTICS, INC.	501 Elliott Ave W Seattle WA 98119	synthesis of non-living compounds that affect cellular signaling pathways to the order and specification of others, for use in medical applications;laboratory research and developmental services in the field of non-living biochemical and therapeutic products that affect cellular signaling pathways;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The present invention relates to highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using therefor. The invention involves a multi-step synthesis to produce the lactam compounds. In one step of the reaction sequence, asymmetric hydrogenation of a lactam-enamide was performed to produce an intermediate that can ultimately be converted to a series of pharmaceutical compounds. The invention also contemplates the in situ synthesis of an intermediate of the multi-step synthesis, which provides economic advantages to the overall synthesis of the lactam compounds.